Some models of brain energy metabolism used to interpret in vivo 13 C nuclear magnetic resonance spectroscopic data assume that intramitochondrial ␣-ketoglutarate is in rapid isotopic equilibrium with total brain glutamate, most of which is cytosolic. If so, the kinetics of changes in 13 C-glutamate can be used to predict citric acid cycle flux. For this to be a valid assumption, the brain mitochondrial transporters of glutamate and ␣-ketoglutarate must operate under physiologic conditions at rates much faster than that of the citric acid cycle. To test the assumption, we incubated brain mitochondria under physiologic conditions, metabolizing both pyruvate and glutamate and measured rates of glutamate, aspartate, and ␣-ketoglutarate transport. Under the conditions employed (66% of maximal O 2 consumption), the rate of synthesis of intramitochondrial ␣-ketoglutarate was 142 nmol/min⅐mg and the combined initial rate of ␣-ketoglutarate plus glutamate efflux from the mitochondria was 95 nmol/min⅐mg. It thus seems that much of the ␣-ketoglutarate synthesized within the mitochondria proceeds around the citric acid cycle without equilibrating with cytosolic glutamate. Unless the two pools are in such rapid exchange that they maintain the same percent 13 C enrichment at all points, 13 C enrichment of glutamate alone cannot be used to determine tricarboxylic acid cycle flux. The ␣-ketoglutarate pool is far smaller than the glutamate pool and will therefore approach steady state faster than will glutamate at the metabolite transport rates measured.
A long-standing goal of neurochemists has been to establish noninvasive techniques to monitor O 2 consumption and citric acid cycle flux in the whole brain (Aureli et al., 1997; Dienel and Hertz, 2001; Gruetter et al., 2001) . With the advent of functional nuclear magnetic resonance (NMR) imaging of the brain that maps areas activated by specific intellectual tasks, the problem has become even more interesting (Ugurbil et al., 2000; Lee and Chang, 2004) . Functional imaging is possible because of local changes in NMR proton relaxation times in activated brain areas (Ogawa et al., 1998) . These proton changes may be due to changes in blood flow, increased O 2 uptake, or increased glycolysis, but if O 2 uptake could be monitored specifically in a spatially resolved way, one could test these possibilities. Likewise, if reliable methods for assessing citric acid cycle flux become available, pathologic conditions could be monitored and areas of neurodegeneration identified.
Some years ago an innovative method was proposed for noninvasively measuring brain glucose oxidation and citric acid cycle flux (Sibson et al., 1997) . Although this method has been used in a number of studies (Sibson et al., 1998 (Sibson et al., , 2001 , it is criticized by others (Gruetter et al., 2001; Henry et al., 2002 Henry et al., , 2003 Xu et al., 2004) . The technique employs C]glutamate appearance in the brain thus provides an unambiguous measure of whole brain glutamate turnover. The assumption is then made that glutamate is in rapid equilibrium with ␣-ketoglutarate and changes in [4-activity of mitochondrial and cytosolic aspartate aminotransferases. A potential flaw in the assumption is that the glutamate monitored is mostly cytosolic whereas the ␣-ketoglutarate, which reflects flux through the citric acid cycle, is inside the mitochondrial matrix space. Mitochondrial transport of ␣-ketoglutarate or glutamate (V x ) across the mitochondrial inner membrane would have to be an order of magnitude faster than citric acid cycle flux (V TCA ) to validate the assumption that the 13 C enrichment in the C-4 of glutamate is always equal to the 13 C enrichment of mitochondrial [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]␣-ketoglutarate. Various tests of the hypothesis have involved examination of the kinetics of appearance of 13 C in [2, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C] of glutamate and of aspartate (Mason et al., 1995; Sibson et al., 1998; Gruetter et al., 2001; Henry et al., 2002) . If the assumption is correct, there would have to be a precursor/ product relationship between [4-13 C]glutamate and [2-13 C] glutamate that appears only in the second turn of the cycle. Some of these analyses have supported the hypotheses (Mason et al., 1992 (Mason et al., , 1995 ; others have not (Gruetter et al., 2001) . Strangely, despite the fairly vigorous controversy, the rate of transport of glutamate and ␣-ketoglutarate into and out of isolated brain mitochondria has not been monitored under physiologic conditions.
The present study was undertaken to estimate flux through ␣-ketoglutarate and glutamate transporters while isolated brain mitochondria were oxidizing pyruvate and glutamate under physiologic conditions. We measured citric acid cycle flux directly using measurements of O 2 consumption and rates of pyruvate and glutamate consumption when both were present in the incubation medium.
Transport of ␣-ketoglutarate and glutamate into and out of the mitochondria was estimated simultaneously. O 2 consumption was set at 66% of its maximal rate. Maximal rates were determined in medium with saturating ADP concentrations (5 mM). Rates of respiration below maximal were established with the aid of a hexokinase/ATP trapping system. The initial concentration of ADP was low (0.1 mM) but the ADP was regenerated with the enzyme hexokinase plus its substrate glucose. Hexokinase phosphorylates glucose to glucose-6-phosphate converting ATP to ADP, and varying hexokinase varies respiration rates. The incubation contained a physiologic concentration of bicarbonate and free Ca 2ϩ was buffered at 0.244 M using an EGTA/Ca 2ϩ buffer (Patton et al., 2004) . The results of the investigation show that under the conditions used, which were designed to maximize the transport rates, ␣-ketoglutarate and glutamate transport are of the same order of magnitude as citric acid cycle flux, not an order of magnitude faster as suggested by other workers (Mason et al., 1995) . The results are discussed in light of new discoveries about the distribution of the aspartate/ glutamate mitochondrial carrier in the brain.
MATERIALS AND METHODS

Isolation of Rat Brain Mitochondria
For isolating brain mitochondria, a modification of the method of Rosenthal et al. (1987) was used, which is one of two methods currently in use. The other method (Clark and Nicklas, 1970) generatessynaptosomal-freemitochondria.Toisolatesynaptosomal-free mitochondria, crude mitochondria are passed through a Ficoll gradient to separate synaptosomes from mitochondria. On the other hand, the method of Rosenthal et al. (1987) breaks the synaptosomal membrane using a low concentration of digitonin, which releases the synaptosomal mitochondria from the synaptosomes. The protease Nagase is also used to break up actin and intermediate filaments.
In our hands, yields from the Rosenthal method (Rosenthal et al., 1987) are about twice as high as that from the Ficoll method (Clark and Nicklas, 1970 ) (ϳ5-6 mg/rat brain) and the respiratory control ratios are higher as well. The Rosenthal method thus seems to provide a more representative sample of total brain mitochondria (neuronal plus glial).
After anesthetizing 300 -400 g male Sprague-Dawley rats, we removed the skull and extracted the whole brain. The cortex was separated from the rest of the brain, minced and washed free of blood with buffer containing 225 mM mannitol, 75 mM sucrose, 5 mM HEPES (pH 7.2), 1 mM EGTA, 1 mg/ml bovine serum albumin (BSA) and then the brain was homogenized in the same buffer with 0.5 mg/ml Nagase added and pH adjusted to 7.3. Homogenate was diluted in buffer containing mannitol, sucrose, and HEPES in the same concentrations as above and mitochondria isolated by differential centrifugation. Digitonin was included in the first high-speed centrifugation but not subsequent ones.
Incubations
Mitochondria were incubated in a buffer containing (in mM): KCl 110; HEPES 20; MgCl 2 5; KH 2 PO 4 5; KHCO 3 25; glucose 5; ADP 0.1; CaCl 2 0.6; EGTA 1; glutamate 5; and pyruvate 1. Hexokinase was added to a final concentration of 2 U/ml. The buffer was equilibrated with 95% O 2 /5% CO 2 and pH adjusted to 7.3.
Malate concentration was 0.5 or 5 mM. Free Ca 2ϩ was set at 0.244 M using the computer program MaxChelator (Patton et al., 2004) to determine the influence of EGTA/Ca 2ϩ ratios on free calcium in our specific medium. Temperature was maintained at 37°C. Ca 2ϩ was set at this concentration because ␣-ketoglutarate dehydrogenase has a k a for free Ca 2ϩ of 0.15 M (Wan et al., 1989) .
Some incubations included [U-14 C]glutamate with a specific activity of ϳ500 dpm/nmol whereas other incubations contained [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]pyruvate at ϳ3,000 dpm/nmol when measuring 14 C-metablites or 500 dpm/nmol when measuring 14 CO 2 production. All incubations included either 5 or 0.5 mM malate.
The reactions were initiated with 0.5-0.8 mg mitochondrial protein. Samples were taken at 0, 2, 4, 6, 8, and 10 min. Protein was precipitated with perchloric acid (final concentration 2%). Total specific activity in the neutralized, protein-free filtrates were determined by scintillation counting.
14 C-Metabolites were separated by ion exchange chromatography using Dowex-1 acetate columns as described previously (Gamberino et al., 1997) . Mass amounts of ␣-ketoglutarate, aspartate, glucose-6-phosphate, glutamate, and pyruvate were determined enzymatically (Bergmeyer, 1965; Williamson and Corkey, 1969) , and protein was measured using the Bio-Rad reagent.
When [2-
14 C]pyruvate was used as the labeled substrate, parallel incubations were run to measure production of 14 CO 2 . Mitochondria were added to vials containing 1 ml of medium preequilibrated with 95% O 2 /5% CO 2 . The vials were sealed with rubber stoppers with a trap (a plastic well containing a fluted square of filter paper) attached. Mitochondria were incubated for 2, 5, or 8 min. At the end of the designated time, 100 l of 1 N NaOH was injected into the filter paper trap and 100 l 20% perchloric acid was injected into the incubation medium. The vials were shaken at room temperature for 2 hr and then 14 C in the filter paper trap was measured by liquid scintillation counting.
O 2 consumption was measured polarographically at 37°C in separate incubations using a closed vessel with a Clark electrode. Figure 1 shows the citric acid cycle, highlighting reactions that produce 2 e Ϫ /molecule. The electrons move through the electron transport chain toward cytochrome oxidase, which uses the electrons to reduce oxygen to H 2 O. The relevant movements of metabolites (glutamate and ␣-ketoglutarate) across the mitochondrial membrane are also shown in Figure 1 . The ␣-ketoglutarate carrier catalyzes exchange of malate for ␣-ketoglutarate. There are two functional glutamate carriers; one catalyzes a unidirectional exchange of protonated glutamate for aspartate and another catalyzes the exchange of glutamate for a hydroxyl ion as illustrated (Palmieri, 2004) . The labeled carbon atom of pyruvate is indicated in Figure 1 as an open circle. Figure 1 shows that this carbon will likely be trapped in the large malate pool of the standard media.
Methods of Calculation
Calculations of fluxes through the various steps are made assuming that certain relationships hold. Symbols have the following meaning:
• ⌬O 2 /⌬t, rate of O 2 consumption (natoms O/min ⅐ mg protein)
• A, pyruvate dehydrogenase flux (nmol pyruvate oxidized/min ⅐ mg protein)
• B, isocitrate dehydrogenase flux (nmol isocitrate oxidized/min ⅐ mg protein)
• C, ␣-ketoglutarate dehydrogenase flux (nmol ␣-ketoglutarate oxidized/min ⅐ mg protein)
• D, succinate dehydrogenase flux (nmol succinate oxidized/min ⅐ mg protein)
• E, malate dehydrogenase (nmol malate oxidized/ min ⅐ mg protein)
• ϩ⌬ asp/⌬t, rate of appearance of aspartate in the me- We then assume: • D ϭ C, and • E ϭ A ϩ ⌬asp/⌬t (the conversion of malate to oxaloacetate is necessary for transamination of glutamate to aspartate).
One can estimate citric acid cycle flux either by measuring ⌬O 2 /⌬t (oxygen consumption) directly and estimating flux through the individual dehydrogenase reactions, or by measuring each step as described above and comparing the sum of the fluxes generating 2e
Ϫ with the rate of O 2 consumption. In this study, the two methods agree within about 20%.
The appearance of ␣-ketoglutarate in the medium is linear for at least 6 min. This initial rate of ␣-ketoglutarate efflux from the mitochondria provides the value of ⌬␣KG/⌬t. The percent changes in glutamate mass were small, but efflux of 14 Cglutamate from the mitochondria could be measured in the these data and the necessary calculations it is possible to compare ␣-ketoglutarate and glutamate transport with citric acid cycle flux.
RESULTS
Glutamate Transport
Glutamate transport (inward) was assessed in the incubations with [U-14 C]glutamate. Mass of glutamate in each sample was measured at each time point with 5 or 0.5 mM malate, but the percent disappearance of glutamate mass was too slow to measure accurately. The disappearance of radiolabeled glutamate was measured in those protocols that included [U-
14 C]glutamate and was rapid enough to obtain an estimate. Moreover, we were able to obtain an estimate of glutamate efflux from the mitochondria when [2- 
␣-Ketoglutarate Transport
The appearance of ␣-ketoglutarate mass in the medium as a function of time in the various incubations is shown in Figure 3 . The initial linearity of the efflux suggests that initial rates represent a unidirectional outward transport process. After 5-6 min, some ␣-ketoglutarate begins to return to the mitochondrial matrix especially in the incubations with 0.5 mM as opposed to 5 mM malate. There was no statistically significant difference in the appearance of ␣-ketoglutarate mass comparing protocols that contained [U-14 C]glutamate as opposed to [2- 14 C]-pyruvate.
Efflux rates are faster at higher levels of malate medium because ␣-ketoglutarate efflux is catalyzed by an exchange carrier that transports ␣-ketoglutarate in exchange for malate (Palmieri, 2004) . We have determined previously that the K m of malate for the ␣-ketoglutarate/ malate exchange in rat heart mitochondria (LaNoue et al., 1973) is 0.36 Ϯ 0.07 mM.
Citric Acid Cycle Flux
If pyruvate were the only substrate, one could easily calculate citric acid cycle flux from O 2 consumption alone or from the consumption of pyruvate because all electronproducing steps (dehydrogenases) would produce electrons at an equal rate. The presence of glutamate as an additional substrate provides some complications. Oxygen consumption was measured in separate incubations in the presence of 5 or 0.5 mM malate. Because we used a hexokinase trap to set O 2 consumption at an intermediate level, we first determined the rate of O 2 consumption with excess ADP (maximum) and then the rate of O 2 consumption with a limiting amount of hexokinase (2 U/ml).
The O 2 consumption under the experimental conditions used in this study was 66% of maximal (Table I) . Rates of O 2 consumption were not affected significantly by the malate concentration used in the incubations. The data used to calculate fluxes through the citric acid cycle are shown in Tables II and III.  Table II provides the   14 C data as a function of time. These values were obtained by separating metabolites generated during the incubations by ion exchange chromatography. The Dowex acetate column routinely used in our laboratory (Lieth et al., 2001 ) separates glutamate, aspartate, and lactate but the citric acid cycle intermediates, citrate, succinate, ␣-ketoglutarate, fumarate, and malate remain on the column and are not eluted. Before running the columns, the [2-14 C]pyruvate in the samples was converted to lactate so that the disappearance of [2-14 C]-radiolabeled pyruvate could be followed (Fig 4) . Separate experiments were designed to measure 14 CO 2 (Fig 4) . Because of the position of the 14 C label on the carbon-2 atom of pyruvate, very little accumulated as 14 CO 2 . Instead, it was trapped as 14 C-malate in the large malate pool (see Fig. 1 ) after one turn of the cycle.
The data of Table III 14 C]-glutamate disappearance was found to be faster than that of glutamate mass (Fig. 2) . In addition, a very significant rate of appearance of [5- 14 C]glutamate from [2-14 C]pyruvate was measured. Using these data for the appearance and (Table II and III) it was possible to calculate flux through the different steps of the citric acid cycle as described above. Results of the calculations are provided in Table IV . The dehydrogenase steps are not all equal because of influx of glutamate and malate, as well as initial rates of ␣-ketoglutarate efflux.
DISCUSSION
The studies reported provide initial rates of metabolite transport out of the mitochondria. The data therefore cannot be extrapolated directly to the in vivo situation in the intact brain because a steady state is maintained for most metabolites in vivo. In this study, the system approaches a quasi-steady state as ␣-ketoglutarate efflux decreases after 6 -8 min. This is because the increased levels of extramitochondrial ␣-ketoglutarate stimulate inward transport.
In the intact brain, however, the rate of ␣-ketoglutarate efflux is probably similar to that observed here, especially at the more physiologic level of malate (0.5 mM). To achieve steady state in the intact brain, some of the cytosolic ␣-ketoglutarate is transaminated to cytosolic glutamate via the cytosolic aspartate aminotransferase and some is probably transported directly back into mitochondria. In this study, glutamate mass decreased because Table III and were obtained by linear regression analysis of the data of Figure 3 . of the absence of cytosolic (medium) transamination; however the glutamate itself can in theory enter and leave the mitochondria. There are two glutamate transporters in brain mitochondria (del Arco and Satrustegui, 1998; Palmieri et al., 2001; Palmieri, 2004) . One is the unidirectional aspartate/glutamate carrier that is expressed as two isoforms, only one of which (Aralar1) is expressed abundantly in brain (Palmieri et al., 2001; Palmieri, 2004 and is electrogenic (del Arco and Satrustegui, 1998; LaNoue and Tischler, 1974) . Because it is driven by the mitochondrial electrical potential, it can only proceed in one direction, glutamate in and aspartate out; therefore, without resynthesis from cytosolic ␣-ketoglutarate, cytosolic glutamate would decline. There is, however, another glutamate transporter in the brain, the glutamate/hydroxyl carrier, and it can run in reverse. Influx on this transporter is required to provide substrate for glutamate dehydrogenase ( Fig. 1 ) and its reversal is probably responsible for the active efflux of glutamate observed in the present experiments and for the very slow decline of glutamate mass. The data presented indicate that the ␣-ketoglutarate/ malate exchanger and the glutamate/hydroxyl carrier catalyze only a partial isotopic exchange with mitochondrial ␣-ketoglutarate. To estimate the extent of this exchange, the rate of synthesis of intramitochondrial ␣-ketoglutarate was compared to the rate that ␣-ketoglutarate and glutamate are exported from the mitochondria.
We estimate that about 66% of the ␣-ketoglutarate synthesized is exported. The rate of synthesis of ␣-ketoglutarate can be estimated as the rate of glutamate entry plus the rate of isocitrate dehydrogenase. At 0.5 mM malate, net glutamate entry is 56 Ϯ 15 nmol/min ⅐ mg and isocitrate dehydrogenase flux is 86 Ϯ 4 nmol/min ⅐ mg. The sum is 142 nmol/min ⅐ mg. That value can be compared to initial rates of efflux of ␣-ketoglutarate (44 Ϯ 3 nmol/min ⅐ mg) plus glutamate (50.9 Ϯ 0.9 nmol/ min ⅐ mg). The sum is 95 nmol/min ⅐ mg or 67% of the rate that ␣-ketoglutarate is synthesized within the mitochondria. It thus seems that about 33% of the mitochondrial ␣-ketoglutarate could proceed around the citric acid cycle without equilibrating with cytosolic glutamate. Similar conclusions can be drawn when 5 mM malate is in the medium.
The data indicate that the use of the kinetics of [4-14 C]glutamate turnover alone in the in vivo brain to estimate citric acid cycle flux underestimates the value. It is possible, as shown by some authors (Gruetter et al., 2001; Henry et al., 2002) , to obtain more accurate values for V TCA by including in the analysis values for glutamate isotopomers generated in the second turn of the citric acid cycle as well as isotopomers of aspartate. Studies similar to those described here have been carried out with rabbit heart mitochondrial (Lewandowski et al., 1997) and directly compared to measurements of citric acid cycle flux 4) . Details of conditions are described in Methods. Except for ⌬O 2 /⌬t, means of rates (nmol/min ⅐ mg) were obtained by linear regression analyses of measured metabolite levels at 0, 2, 4, and 6 min. *P Ͻ 0.001 significantly different from 5 mM. in intact perfused rabbit hearts perfused with 13 C substrates (Lewandowski et al., 1997; O'Donnell et al., 1998 O'Donnell et al., , 2004 Griffin et al., 2000) . Glutamate dehydrogenase and the glutamate/hydroxyl carrier are very active and functionally important in brain Zaganas et al., 2001 ) but much less active in hearts, making the analysis more complex in the brain than the heart. In the intact hearts, the rates monitored by [4-13 C]glutamate correlate directly with expression of the mitochondrial ␣-ketoglutarate/malate exchanger (Griffin et al., 2000) and do not correlate with citric acid cycle flux (Lewandowski et al., 1997; O'Donnell et al., 1998 O'Donnell et al., , 2004 . In most 13 C NMR spectroscopic studies that focus on energy metabolism, the citric acid cycle flux is abbreviated as V TCA and the metabolite efflux as V x . The kinetic model used to calculate fluxes in the heart can be verified independently by measuring V TCA (citric acid cycle flux) independently by other techniques (such as O 2 consumption or substrate consumption). The cardiac data suggest that V x routinely is lower than V TCA (Lewandowski et al., 1997; O'Donnell et al., 1998 O'Donnell et al., , 2004 Griffin et al., 2000) .
The situation is likely to be somewhat more complicated in the brain because of the higher activity of the glutamate/hydroxyl carrier and the activity of glutamate dehydrogenase. The kinetics of [4-13 C]glutamate turnover, however, may provide a useful way to monitor glutamate transport across the mitochondrial membrane and estimate the malate/aspartate shuttle.
The malate/aspartate shuttle is the most active and most commonly used shuttle required to transfer reducing equivalents from the cytosol to the mitochondria (Meijer, 2003) . Reducing equivalents (i.e., NADH) are generated in the cytosol by conversion of lactate to pyruvate via cytosolic lactate dehydrogenase, and by conversion of glucose to pyruvate via the glycolytic pathway.
Because NADH is impermeable to the mitochondrial membrane, a metabolite shuttle system is needed to move the electrons from NADH into the mitochondria where oxidative phosphorylation can generate 2.5 molecules of ATP from the energy made available by transfer of these electrons (2e Ϫ /molecule NADH) down the electron transfer chain.
The step in the malate/aspartate shuttle that actually moves the electrons into the mitochondria is the exchange of cytosolic malate for mitochondrial ␣-ketoglutarate. The malate picks up the electrons from NADH via cytosolic malate dehydrogenase. The ␣-ketoglutarate efflux from mitochondria partially monitored in the intact brain via the appearance of [4-13 C]glutamate may thus provide an estimate of the malate/aspartate shuttle.
Because glucose is the major oxidative substrate of the brain whereas hearts instead prefer fatty acids as substrates, it seems that the in vivo [4-
13 C]glutamate kinetics in the brain may approximate flux through the malate/ aspartate cycle, thereby monitoring glucose oxidation. Glucose consumption generates 2 nmol of NADH in the cytosol for each nmol of glucose. In the absence of oxygen or the absence of an NADH shuttle, the product of glucose metabolism is lactic acid; however, it has been made clear recently that not all brain cells have a functional malate/aspartate shuttle (Ramos et al., 2003) . Another transporter required for operation of the shuttle is the aspartate/glutamate carrier. A recent careful study of the expression of this carrier in brain (Ramos et al., 2003) indicates that it is not expressed in brain astrocytes. Because astrocytes are known to export lactate as a major product of glucose metabolism (Tsacopoulos and Magistretti, 1996) , the absence of an NADH shuttle in these cells perhaps is not surprising. The brain ␣-ketoglutarate pool is ϳ0.1% of the brain glutamate pool. The measurements of ␣-ketoglutarate and glutamate transport made as part of this study indicate that the transporters catalyze fluxes similar to those of the citric acid cycle. If the specific activity of glutamate and ␣-ketoglutarate change at equal rates, and if the source of label was only pyruvate dehydrogenase, the transporter flux would have to be an order of magnitude faster. This is clearly not the case. However, estimates of V TCA made by perfusing brains with [1- .
The reason for this may be that glucose is a major oxidative substrate for the brain and glucose cannot be oxidized without consumption of the cytosolic NADH generated by glycolysis. This consumption involves movement of 2e
Ϫ from NADH to malate and exchange of intramitochondrial ␣-ketoglutarate for malate, which is then oxidized by malate dehydrogenase. From Table IV , it is apparent that in our in vitro study malate dehydrogenase flux is faster than ␣KG dehydrogenase by more than a factor of two. If allowed to proceed to steady state with a complete malate/aspartate cycle supporting glucose oxidation, malate dehydrogenase would proceed at twice the rate of the other citric acid cycle enzymes. Glutamate would exchange with aspartate at the same rate as pyruvate oxidation (from glucose). This would explain why glutamate turnover in the brain provides a good estimate of citric acid cycle flux, but in other organs where citric acid cycle flux is not linked to glucose oxidation glutamate turnover does not provide a reliable estimate.
